HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: How effective are the changes in the national blood transfusion policies?

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 1, 2010, Pages 41-46

  Acar, Ali ^a   Kemahli, Sabri ^b   Altunay, Husnu ^c   Kosan, Erdogan ^c   Oncul, Oral ^a   Gorenek, Levent ^a   Cavuslu, Saban ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Capa Red Crescent Blood Centre   (Turkey)

Author keywords

Blood donors; HBV; HCV; HIV; Seroprevalence; Turkey

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; AWARENESS; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; FALSE POSITIVE RESULT; HEALTH CARE POLICY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL INFORMATION; MICROPARTICLE ENZYME IMMUNOASSAY; NONHUMAN; SCREENING TEST; SENSITIVITY ANALYSIS; SEROPREVALENCE; TURKEY (REPUBLIC);

EID: 77954764628     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702010000100009     Document Type: Article

References (20)

1. Kaur P, Basu S. Transfusion-transmitted infections: existing and emerging pathogens. J Postgrad Med 2005; 51(2):146-51.
2. Bihl F, Castelli D, Marincola F, Dodd RY, Brander C. (2007). Transfusion-transmitted infections. J Transl Med 2007; 6; 5:25.
3. Alter HJ, Houghton M. Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med 2000; 6(10):1082-6.
4. Heper Y. Transfüzyonda Mikrobiyolojik Tarama Testleri. Antibiyotik ve Kemoterapi Dergisi 2007; 21(Ek 2):146-52.
5. Özdemir D, Kurt H. Hepatit B Virüsü Enfeksiyonlarinin Epidemiyolojisi. In: Tabak F, Balik İ, Tekeli E. ed. Viral Hepatit 2007, 1. Baski. İstanbul: Viral Hepatitle Savaşim Derneǧi, 2007; s.:108-17.
6. Mistik R. Türkiye'de viral hepatit epidemiyolojisi yayinlarinin İrdelenmesi. In: Tabak F, Balik İ, Tekeli E. ed. Viral Hepatit 2007, 1. Baski. İstanbul: Viral Hepatitle Savaşim Derneǧi, 2007; s.:10-50.
7. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006; 21(4):299-305
8. Kocak N, Hepgul S, Ozbayburtlu S et al. Trends in major transfusion-transmissible infections among blood donors over 17 years in Istanbul, Turkey. J Int Med Res 2004; 32(6):671-5.
9. Sakarya S, Tuncer G, Yaşar H, Cicek C, Kadikoylu G, Yukselen V. Aydin Bölgesi Kan Dönerlerinde HBsAg ve Anti-HCV Seroprevalansi ve Yaş ve Cinsiyetle İlişkisi. Klimik Dergisi 2001; 14:22-4
10. Sünbül M. HCV Enfeksiyonun epidemiyolojisi. Viral Hepatit 2007, 1. Baski. Ed., Tabak F, Balik İ, Tekeli E. İstanbul: Viral Hepatitle Savaşim Derneǧi, 2007; s.:208-19.
11. 11. Accessed Jan 2, 2009.
12. http://www.saglik.gov.tr/istatistikler/istatistikyilliklari/Temel Saǧlik Hizmetleri Genel Müdürlüǧü Çalişma Yilliǧi 2006. Accessed Jan 2, 2009.
13. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Recomm Rep 1991; 19; 40(RR-4):1-17.
14. Dufour DR. Hepatitis B surface antigen (HBsAg) assays: are they good enough for their current uses? Clin Chem 2006; 52(8):1457-9.
15. Chen D, Kaplan L. The performance of a new generation chemiluminescent assay for hepatitis B surface antigen. Clin Chem 2006; 52:1592-8.
16. O'Brien J. Hepatitis B surface antigen: decreased need for confirmation of reactive results. Clin Chem 2000; 46:582.
17. Kiely P, Kay D, Parker S, Piscitelli L. The significance of thirdgeneration HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. Transfusion 2004; 44(3):349-58.
18. Cavazza S, Lagging M. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors. Scand J Infect Dis 2005; 37(6-7):488-92.
19. Rothman RE, Merchant RC. Update on emerging infections from the Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Ann Emerg Med 2007; 49(5):575-9.
20. Vardinon N, Yust I, Katz O et al. Anti-HIV indeterminate western blot in dialysis patients: a long-term follow-up. Am J Kidney Dis 1999; 34(1):146-9.